Phenotype | Clinical Symptoms (prior to treatment) | Biochemical | % BCKD activity |
Classical | Neonatal onset, poor feeding, lethargy, altered tone, ketoacidosis, seizures. Symptoms often present prior to learning NBS results. Prenatal testing in at-risk siblings can allow dietary intervention at birth. Nearly all due to mutations in the E1 BCKD subunits | ↑↑ allo-ILE, BCAA, BCKA | 0 -2 |
Intermediate | Failure to thrive, ketoacidosis and developmental delay; classical symptoms can occur during catabolic illness/stress | ↑ allo-ILE, BCAA, BCKA | 3 - 30 |
Intermittent | Normal early development, episodic ataxia/ketoacidosis, severe symptoms may be precipitated by catabolic illness/stress. May be missed by MS/MS NBS | Normal BCAA, BCKA when asymptomatic | 5 - 20 |
Thiamin (B1) responsive | Similar to intermediate. Often due to mutations in E2 BCKD subunit | ↑ allo-ILE, BCAA, BCKA ↓BCKA and/or BCAA with thiamin therapy | 2 - 40 |
Lipamide dehydrogenase deficiency | Normal neonatal period, failure to thrive, hypotonia, lactic acidosis, developmental delay, movement disorder. Due to mutations in the E3 BCKD subunit - a component of both pyruvate dehydrogenase and α-ketoglutarate dehydrogenase | Moderate BCAA and BCKA, ↑α-ketoglutarate, pyruvate | 0 - 25 |
Laboratory test/symptom | Symptomatic | Pre-symptomatic/treated |
MS/MS NBS on blood spot | ↑↑BCAA, especially LEU; LEU:PHE ratio > 4.5-5 | <24 hr of age : normal or slight ↑BCAA; > 24 hr of age : slight ↑to ↑BCAA Treated in good control: normal or slight ↑BCAA |
Plasma amino acids | ↑↑BCAA (especially LEU), allo-ILE present; without TX, VAL and ILE may become normal or low. As LEU increases, see decreases in other essential and non-essential AA | normal or slight ↑BCAA; allo-ILE present |
Urine DNPH Rx | ++ after day 2-3 of life | - |
Urine organic acid analysis | ↑BCKA | normal or slight ↑ |
Ketonuria (urine keto sticks) | ++ | - |
Ammonia | May be ↑ or ↑↑ | - |
BCKD activity | 0-3% | 0-3% |
Blood glucose | ↓ or normal | normal |
Weight | ↓ | normal |
Lethargy, intermittent apnea, opisthotonus | + | - |
Maple syrup odor (in urine) | + usually by 72+ hr, (first apparent in cerumen by 12-24 hr) | - |
Irritability, poor feeding | + | - |
Vomiting | + | - |
Ataxia | + | - |
Visual hallucinations | + | - |
Coma, respiratory failure by 7-10 days of life without treatment | + | - |
Nutrient | Recommendation | Source |
LEU | Sufficient intake to allow adequate protein synthesis for growth, repair and health maintenance and to achieve LEU levels in recommended treatment range. LEU allowance is also dependent on residual BCKD activity, age, weight, sex, life stage and health of the individual with MSUD. In the newborn, the recommended intake is: 40-100 mg LEU/kg/day |
In infants: breast milk or infant formula with known LEU content In children and adults: foods such as fruits/vegetables, some grains/cereals that are typically low in protein and for which there is known LEU content |
PRO | DRI 1 Plus additional 20-40% if an amino acid-based medical food is used |
|
VAL, ILE | VAL and ILE are essential amino acids and may need to be supplemented when BCAA are restricted to achieve appropriate LEU blood levels. To promote anabolism of LEU, when LEU blood levels are high, additional supplementation of VAL and ILE is often required |
|
KCAL | DRI 1 |
|
Other nutrients, minerals and vitamins 5 | DRI 1 |
|
1 For age, size, sex, and life stage. Requirements change with catabolic illness/conditions
2 1% solutions are convenient for adding to the medical food when supplementation is necessary
3 Free foods contain little or no detectable PRO/BCAA and consist mostly of sugars, pure starches and/or fats
4 Modified low-protein foods include pastas and baked goods where higher protein grains/flours are replaced by protein-free starches
5 Included are essential fatty acids and DHA, Vit D, Vit A, Ca, Fe, Zn, Se
6 Most BCAA-free medical foods are supplemented sufficiently with the nutrients and micronutrients that may be deficient in a diet low in BCAA. Compliance with taking the full medical food prescription is important in meeting these nutrient requirements. In addition, there are some medical foods that have been modified to improve taste, decrease KCAL or volume in order to increase compliance that may have insufficient supplementation of some micronutrients, vitamins and minerals
AGE/ STAGE | NUTRIENT | |||||
LEU 1,2 mg/kg | Approximate Intact PRO5 g/kg | ILE2,3,4 mg/kg | VAL2,3,4 mg/kg | Total PRO6 g/kg | ENERGY7 kcal/kg | |
INFANTS TO < 4 yr (classical to mild MSUD) | ||||||
0 - <3 mo | 60-100 | 1.0-1.6 | 36-100 | 40-95 | 2.5-3.0 | 118-130 |
>3 - <6 mo | 50-85 | 0.8-1.4 | 30-80 | 35-90 | 2.0-3.0 | 102-111 |
>6 - <12 mo | 35-70 | 0.6-1.2 | 25-70 | 30-80 | 2.0-2.5 | 100-107 |
≥1 - <4 yr | 25-55 | 0.4-0.9 | 20-60 | 25-70 | 1.5-2.1 | 105-114 |
AGE/ STAGE | AFTER EARLY CHILDHOOD (classical MSUD) | |||||
LEU2 mg per day | Intact PRO5 g per day | ILE3,4 mg per day | VAL3,4 mg per day | Total PRO6 g | ENERGY kcal | |
>4 yr | 275-500 | 5.0 - 8.0 | 250-450 | 325-500 | 120% DRI8 | DRI8 |
AGE/ STAGE | PREGNANCY9,10 and POSTPARTUM (classical MSUD) | |||||
LEU3 mg per day | Intact PRO5 g per day | ILE3,4 mg per day | VAL3,4 mg per day | Total PRO6 g/day | ENERGY kcal/day | |
1st trimester10 | 300 -500 | 5.0 - 8.0 | 250-450 | 325-500 | 120% DRI plus 0.5g/d | DRI plus 85 kcal/d |
2nd trimester | 600-1000 | 10 - 16 | 400-800 | ~600-1000 | ~120 % DRI plus 7.7g/d | DRI plus 285 kcal/d |
3rd trimester | 800-2000 | 13 - 33 | 650-1200 | 800-1800 | 120% DRI plus 25g/d | DRI plus 375 kcal /d |
Postpartum | If not breast feeding, return to pre-pregnancy intake 11 | |||||
Lactation | Intake while breastfeeding should be approximately the same as in the 3rd trimester |
Sources: G.43; G.50; G.39; F.426; F.3481; F.102; F.3482; F.3483, Nominal Group summary and Delphi Surveys
1 For individuals with classical MSUD, especially in infancy, use of LEU content of foods/infant formulas is more accurate than relying of the rounded PRO content.
2 Individuals with "classical MSUD" tolerate BCAA and intact PRO intake at the lower end of the range.
3 Actual intake should be guided and adjusted based on results from plasma amino acid and anthropometric monitoring.
4 Source(s) of VAL and ILE are from intact PRO and possible supplementation of (the individual) amino acids.
5 Estimated from a mixed diet to be approximately 60mg LEU per gram intact PRO
6 Combination of intact PRO (providing the increased requirements for BCAA) and PRO equivalents from amino acid-based medical food
7 Energy intake recommendations from birth to <4 years are derived from the Human Energy Requirements Report of a Joint FAO/WHO/UNU Expert Consultation 2001 for the general public - see: http://www.fao.org/3/a-y5686e.pdf with an additional 10% added for those individuals who obtain the majority of their protein calories from amino acids (G.50)
8 DRI (Daily Intake Requirements) are based on age, sex, activity level and BMI - see:
https://fnic.nal.usda.gov/dietary-guidance/dri-nutrient-reports/energy-carbohydrate-fiber-fat-fatty-acids-cholesterol-protein.
9 Women who are < 19 years of age and women having multiple births have higher nutrient requirements
10 Women may need to adjust their current intake to meet appropriate plasma levels of the BCAA if diet was not being strictly followed at the time of conception. BCAA, PRO and energy needs begin to increase toward the end of the first trimester
11 See MSUD guideline's text for recommendations for the labor/delivery and immediate post-partum periods
Nutrition Diagnosis (Problem) | Related to (Etiology) | As Evidenced By (Signs and Symptoms) |
Based on assessment findings, specify the current nutrition-related problem(s) to be addressed through nutrition management. | Identify the most pertinent underlying cause(s) or contributing risk factors for the specific problem. The etiology is commonly the target of nutrition intervention. | List subjective and objective data that characterize the specific problem and are also used to monitor nutrition intervention and outcomes. |
Examples of specific nutrition problems: | Examples of underlying causes of the problem: | Examples of data used to determine and monitor the problem: |
Intake Domain Excessive protein intake Insufficient protein intake Intake of types of protein or amino acids inconsistent with needs (specify) Predicted excessive energy intake Predicted suboptimal energy intake Excessive fat intake Inadequate fat intake Excessive enteral nutrition infusion Inadequate enteral nutrition infusion Enteral nutrition composition inconsistent with needs Clinical Domain Impaired nutrient utilization Altered nutrition-related lab values Food-medication interaction (specify) Growth rate below expected Underweight Overweight/obesity Behavioral-Environmental Domain Food and nutrition-related knowledge deficit Limited adherence to nutrition-related recommendations Limited access to food | Consumption Factors Lack of medical food consumption Suboptimal medical food consumption Excessive intake of (specify food or beverage) Provider Factors Nutrition prescription no longer meets protein needs Nutrition prescription no longer meets energy needs Underlying Disease Factors New diagnosis of MSUD LEU, VAL, and ILE restriction necessary for MSUD treatment Acute illness or infection Poor appetite due to (specify) Patient/Caretaker Knowledge and Behavior Factors Food choices suboptimal Lack of knowledge Limited adherence to dietary therapy recommendations Presentation to clinic for initial nutrition education Off diet Access Factors Lack of financial resources for medical food and low-protein foods Lack of medical insurance Inadequate third-party or denial of coverage for medical foods or low protein foods Lack of access to resources or care | From Biochemical Tests Laboratory value compared to norm or goal (specify) (e.g. plasma LEU of 300 µmol/L) Abnormal plasma amino acids (specify) Presence of ketones in urine Positive DNPH test From Anthropometrics Growth pattern, weight, weight-for-height or BMI compared to standards (specify) Weight gain/loss (specify weight change) over the past (specify time frame) From Clinical/Medical Exam or History New diagnosis of MSUD EFA deficiency (physical sign or lab value) From Diet History Estimated or calculated intake from diet record or dietary recall, compared to recommendation or individual's nutrition prescription (specify) From Patient Report Verbalized lack of skill or understanding to implement nutrition recommendations Lack of appreciation for the importance of making nutrition-related changes Lack of social or familial support |
Table content is based on Nutrition Care Process (NCP) terminology developed by the Academy of Nutrition and Dietetics. NCP uses the following structure for documenting nutrition problems: nutrition diagnosis (Problem), related to (Etiology), and as evidenced by (Signs and Symptoms). Examples listed identify concerns particular to MSUD and are grouped in domains of: Intake, Clinical, and Behavioral-Environmental. Problems identified may relate to any Etiology and be evidenced by any Signs and Symptoms within a domain.
Domain Measures | Infants | Children | Children | Adults | Planning Pregnancy or Pregnant | Postpartum and Lactation |
Assessment of Clinical Status 2 Physical findings, growth, and laboratory results should be within normal for age, sex, and life stage, except for blood levels of BCAA 5 | ||||||
Nutrition assessment and counseling (dietary intake3 and nutrient analysis, nutrition-related physical findings, nutrition counseling, diet education) | Weekly to monthly | Monthly to every 6 months | Every 6 to 12 months | Every 6 to 12 months | Monthly to per trimester | At 6 weeks postpartum, then every 6 months |
Interim nutrition contact (diet adjustment based on blood BCAA levels, or counseling at clinic or by phone/electronic communication) | Twice weekly to weekly | Weekly to monthly | Weekly to monthly | Monthly | Once to twice weekly | Weekly to monthly |
Anthropometrics (weight, length or height, weight for length or BMI, head circumference through 36 months and as indicated) | At every clinic visit; include head circumference | At every clinic visit; include head circumference until age 4 years | At every clinic visit | At every clinic visit | At every clinic visit; include growth of the fetus | At every clinic visit; assess growth of the offspring during lactation |
Assessment of Biochemical Status (Monitoring and Routine)4 | ||||||
Leucine (plasma, serum, or whole blood)5 | Daily, until stabilized. Once to twice weekly until 6 months, then weekly | Weekly until 24 months, then monthly | Monthly | Monthly | Weekly | Weekly until 6 weeks postpartum then monthly |
Valine, isoleucine, alloisoleucine (plasma, serum, or whole blood)5 | Daily, until stabilized. Once to twice weekly until 6 months, then weekly | Weekly until 24 months, then monthly | Monthly | Monthly | Weekly | Weekly until 6 weeks postpartum then monthly |
a-keto acids (or ketones)6 | Daily, until stabilized. Once to twice weekly until 6 months, then weekly | Weekly until 24 months, then monthly | Monthly | Monthly | Weekly | Weekly until 6 weeks postpartum then monthly |
Amino acids, plasma (full panel) | Monthly | Monthly until 24 months, then every 6 months | With every clinic visit/ assessment | With every clinic visit/ assessment | With every clinic visit/ assessment | With every clinic visit/ assessment |
Transthyretin (prealbumin) | Every 6 months | Every 6 months | With every clinic visit/ assessment | With every clinic visit/ assessment | With every clinic visit/ assessment | With every clinic visit/ assessment |
Albumin | Every 6 months | Every 6 months | With every clinic visit/ assessment | With every clinic visit/ assessment | With every clinic visit/ assessment | With every clinic visit/ assessment |
Complete Blood Count (CBC) | Every 6 months | Every 6 months | ​​​​​​​With every clinic visit/ assessment | ​​​​​​​With every clinic visit/ assessment | ​​​​​​​With every clinic visit/ assessment | ​​​​​​​With every clinic visit/ assessment |
Ferritin | Every 6 months | Every 6 months | ​​​​​​​With every clinic visit/ assessment | ​​​​​​​With every clinic visit/ assessment | ​​​​​​​With every clinic visit/ assessment | ​​​​​​​With every clinic visit/ assessment |
Assessment of Biochemical Status (Conditional)7 When nutritional assessment indicates poor compliance with diet or inadequate medical food consumption, or there has been consumption of an incomplete medical food, clinical signs/symptoms of nutritional inadequacy including poor growth, or serious intercurrent illness or metabolic decompensation, these laboratory indices should be evaluated. If laboratory values are abnormal, reassessment of specific analytes should be scheduled within one month of intervention. | ||||||
25-OH vitamin D | In addition, preconceptually or as soon as pregnancy is confirmed | In addition, once in the postpartum period | ||||
Vitamin B12 | In addition, preconceptually or as soon as pregnancy is confirmed | In addition, once in the postpartum period | ||||
RBC essential fatty acids | In addition, preconceptually or as soon as pregnancy is confirmed | In addition, once in the postpartum period | ||||
Trace minerals (Zn, Cu, Se) | In addition, preconceptually or as soon as pregnancy is confirmed | In addition, once in the postpartum period | ||||
Vitamin A | In addition, preconceptually or as soon as pregnancy is confirmed | In addition, once in the postpartum period | ||||
Comprehensive metabolic panel | In addition, preconceptually or as soon as pregnancy is confirmed | In addition, once in the postpartum period | ||||
Folic acid8 | In addition, preconceptually or as soon as pregnancy is confirmed | In addition, once in the postpartum period | ||||
L-carnitine (free, esterified and total)8 | In addition, preconceptually or as soon as pregnancy is confirmed | In addition, once in the postpartum period | ||||
Radiologic | ||||||
DEXA scan (Dual-energy X-ray absorptiometry) | n/a | n/a | Every 3 to 5 years beginning at age 8 years if low vitamin D or frequent fractures | If low vitamin D or frequent fractures | n/a | n/a |
Ultrasound | n/a | n/a | n/a | n/a | First trimester, 18 to 20 weeks then every 4 weeks until delivery | n/a |
Echocardiogram (fetal) | n/a | n/a | n/a | n/a | 18 to 20 weeks | n/a |
​​​​​​​1 Intervention and monitoring during catabolic illness or at the time of diagnosis is covered in Question1 in the Nutrition Recommendation Section of the Guideline.
2 The recommended frequency of clinical assessments at a metabolic clinic (involving the medical geneticist, metabolic dietitian, social worker, nurse specialist, psychologist, et al.) may not be possible because of travel distance, cost, loss of work days, etc. Coordination with primary care providers, use of telemedicine, and frequent communication by telephone and mail should be employed.
3 A mechanism for assessing dietary intake, whenever BCAA monitoring is done, should be in place.
4 Consensus from the Delphi 1 and 2
5 There are some programs that have monitoring protocols allowing for mail-in samples (using Guthrie cards or small vials) or use of local labs. Such protocols are optimal for increasing the frequency of monitoring.
6 The dinitrophenylhydrazine (DNPH) test is the more accurate test for measuring the branched chain a-ketoacids. If the clinic cannot provide this for home use, then ketosticks are an alternative.
7 There was no consensus from the Delphi 1 and 2 surveys that these tests should be done routinely, but specific circumstances (as listed) may indicate the need for specific tests.
8 Rarely of concern except during pregnancy
Classification1 | Complete | No added fat | Amino Acids |
Nutrient Profile | Amino acids, carbohydrates, fats, vitamins and minerals | Amino acids, carbohydrates, vitamins and minerals | No carbohydrates or fats; few or no vitamins and minerals |
Pro: energy ratio (PRO g/100kcal)2 | Low to medium | Medium to high | High |
Forms | Powder, bars | Powder, ready-to-drink | Powder |
Products designed for infants | BCAD 17, Ketonex-16, MSUD Analoge | None | None |
Products designed for children3 | BCAD 27 Complex Junior MSD5 Complex Essential MSD5 Complex MSD Amino Acid Bars10 Ketonex-26 | Camino Pro MSUD9 Milupa MSUD 25 MSUD Gel8 MSUD Express 158, MSUD Express 208 MSUD Cooler 158 MSUD Lophlex LQ5 MSUD Maxamaid5 | None |
Products designed for adolescents and adults4 | BCAD 27 Complex Essential MSD5 Complex MSD Amino Acid Bars10 Ketonex-26 | Camino Pro MSUD9 Milupa MSUD 25 MSUD Express 158 MSUD Express 208 MSUD Cooler 158 MSUD Lophlex LQ5 MSUD Maxamum5 | Complex MSD Amino Acid Blend5a |
1. Examples of products available in the U.S. as of August 2014. Inclusion in table does not represent endorsement
2. Energy/Protein ratio categories ((PRO g/100kcal): High: 11-25; Medium 5-10; Low <5
3. Some products not appropriate for children <4 years; check manufacturer’s information for nutrient profile
4. Some products may be used before adolescence, especially if used in combination with other products, depending on clinical circumstances
5. Nutricia North America, Gaithersburg, MD (including Applied Nutrition)
6. Abbott Nutrition, Columbus OH
7. Mead Johnson Nutrition, Evansville IN
8. Vitaflo USA, Alexandria, VA
9 Cambrooke Foods, Ayer, MA
10. Complex MSD Amino Acid Bars have a low PRO: energy ratio but no added vitamins and minerals.
AGE | INFANTS 0 - <3 mos (classical to mild MSUD) | ||||||
NUTRIENT | |||||||
LEU mg/kg | Approx Intact PRO g/kg | ILE mg/kg | VAL mg/kg | Total PRO g/kg | ENERGY kcal/kg | FLUID mL/kg | |
0 - <3 mos | 60-100 | 1-1.6 | 36-100 | 40-95 | 2.5-3.0 | 118-130 | 125-160 |
As there is a range in the recommendations for the BCAA, energy and PRO, monitoring growth, clinical status and biochemical markers is essential when prescribing the nutrient intake for any individual with MSUD. Some individuals may need intakes outside the recommended ranges for optimal outcome.
This table is an excerpt of TABLE #4, Recommended Dietary PRO, BCAA and Energy Intake from the Nutrition Management Guideline for MSUD where more details are provided.
Components | Amount | LEU mg | Approx | ILE mg | VAL mg | Total PRO g | Energy Kcal |
Breast milk (mature) | 100 mL | 100 | 1.07 | 58 | 56 | 1.07 | 72 |
MSUD Analog | 100 g | 0 | 0 | 0 | 0 | 13 | 475 |
Similac Advance | 100 g | 1080 | 10.6 | 575 | 640 | 10.6 | 510 |
This table is an excerpt of TABLE #7, Classification of Medical Foods for MSUD from the Nutrition Management Guideline for MSUD
Components | AMT | LEU mg | Approx | ILE mg | VAL mg | Total | Energy Kcal |
Breast milk | 266 mL | 266 | 2.85 | 154 | 149 | 2.85 | 192 |
MSUD Analog | 52 g | 0 | 0 | 0 | 0 | 6.76 | 248 |
Non-PRO energy source | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Supplemental VAL | 10.6 mL1 | 0 | 0 | 0 | 106 | (10.6) | 0 |
Supplemental ILE | 7.4 mL1 | 0 | 0 | 74 | 0 | (7.4) | 0 |
Final volume | 600 mL | 0 | 0 | 0 | 0 | 0 | 0 |
TOTAL | 600 mL/ 20 fl oz | 266 | 2.85 | 228 | 255 | 9.6 | 440 22 kcal/oz |
Per kg BW | 70 | 0.75 | 60 | 67 | 2.5 | 116 |
1 Derived from 1% solutions containing 10 mg/mL. Alternatively, powders containing 106 mg pure VAL or 74 mg pure ILE can be added during preparation of the formula mix.
Rounding: The above chart provides exact calculations; however, to make it more user-friendly for families, consider rounding the volume of breast milk, medical food and supplemental VAL and ILE to make preparation easier, as in TABLE #11, Rounded Calculation of Formula Mix to Meet Recommended Intake for Case 3.1: using breast milk below. This will not have a significant impact on blood BCAA or nutrient composition of the formula mix. From this point on, case studies will show the rounded values.
Components | Amount | LEU mg | Approx Intact PRO g | ILE mg | VAL mg | PRO g | Energy Kcal |
Breast milk | 270 mL | 270 | 2.89 | 157 | 141 | 2.89 | 194 |
MSUD Analog | 55 g | 0 | 0 | 0 | 0 | 7.15 | 261 |
Non-PRO energy source | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Supplemental VAL | 10 mL | 0 | 0 | 0 | 100 mg | 0 | 0 |
Supplemental ILE | 7 mL | 0 | 0 | 70 | 0 | 0 | 0 |
Final volume | 600 mL | ||||||
TOTAL | 600 mL/ 20 fl oz | 270 | 2.89 | 227 | 241 | 10.0 | 455 23 kcal/oz |
Per kg BW | 158 mL | 71 | .76 | 60 | 63 | 2.6 | 120 |
Prepare the mixture as above, and offer 2-3 oz per feeding. Each infant is different and it is important to pay attention to feeding/hunger cues and feed accordingly.
Components | Amount1 | LEU mg | ILE mg | VAL mg | PRO g | Energy Kcal |
Similac Advance™ | 25 g | 266 | 144 | 160 | 2.7 | 128 |
MSUD Analog™ | 55 g1 | 0 | 0 | 0 | 7.3 | 266 |
Non-PRO energy source (ProPhree™)2 | 10 g | 0 | 0 | 0 | 0 | 48 |
Supplemental VAL | 8 mL1,3 | 0 | 80 | 0 | 0 | 0 |
Supplemental ILE | 10 mL 1,3 | 0 | 0 | 100 | 0 | 0 |
Final volume | 600 mL | |||||
TOTAL | 600 mL (20 fl oz) | 266 | 224 | 260 | 10.0 | 442 kcal 22 Kcal/ oz |
Per kg BW | 158 mL | 70 mg | 60 mg | 67mg | 2.6 g | 116 kcal |
1 It will not adversely affect outcome to round amounts: e.g,.55 g Analog; 8 mL supplemental VAL; 10 mL supplemental ILE
2 Alternately, the formula mixture can be prepared using 65 g MSUD Analog™, with the additional 10 g of the BCAA-free medical food providing the 48 kcal.
3 1% solutions containing 10 mg/mL. Alternatively, powders containing 80 mg pure VAL or 100 mg pure ILE can be added to the formula mixture
AGE/STAGE | INFANTS ≥6 - <12 mo (classical to mild MSUD) | |||||
NUTRIENT | ||||||
LEU mg/kg | Approx Intact PRO g/kg | ILE mg/kg | VAL mg/kg | Total PRO g/kg | ENERGY kcal/kg | |
≥6 - <12 mo | 35-70 | 0.6-1.2 | 25-70 | 30-80 | 2.0-2.5 | 100-107 |
As there is a range in the recommendations for the BCAA, energy and PRO, monitoring growth, clinical status and biochemical markers is essential when prescribing the nutrient intake for any individual with MSUD. Some individuals may need intakes outside the recommended ranges for optimal outcome. If monitoring results are consistent with good control, dietary modifications such as introduction of solid foods or change in formula mixture should be based on current intake.
This table is an excerpt of TABLE #4, Recommended Dietary PRO, BCAA and Energy Intake from the Nutrition Management Guideline for MSUD where more details are provided.
Components | Amount | LEU mg | Approx | ILE mg | VAL mg | PRO g | Energy kcal |
Good Start | 33 g | 378 | 3.7 | 190 | 196 | 3.7 | 169 |
Ketonex-1 | 105 g | 0 | 0 | 0 | 0 | 15.8 | 504 |
Isoleucine 50 | 2 sachets | 0 | 0 | 100 | 0 | 0.1 | 31 |
Valine 50 | 2 sachets | 0 | 0 | 0 | 100 | 0.1 | 31 |
Water | Add water to make a final volume of 32oz | ||||||
Total | 32 oz/ 960mL | 378 | 3.7 | 290 | 296 | 19.7 | 735 23 kcal/oz |
Per kg BW | 47 mg | 0.46 g | 36 mg | 37 mg | 2.5g | 92 kcal |
Components | Amount | LEU mg | ILE mg | VAL mg | PRO gm | Energy kcal |
Good Start™ | 30 g | 344 | 173 | 179 | 3.4 | 154 |
Ketonex-1™ | 105 g | 0 | 0 | 0 | 15.8 | 504 |
Solid foods, intact PRO | Varies | 30 | varies | Varies | ~0.5 | Varies |
Isoleucine 50 | 2 sachets | 0 | 100 | 0 | 0.1 | 31 |
Valine 50 | 2 sachets | 0 | 0 | 100 | 0.1 | 31 |
Total | 375 | 291 | 305 | 20.0 | 720 + food | |
Per kg | 47 mg | 36 mg | 38 mg | 2.5 g | ~95 kcal |
Suggested Time | Formula or Food | Amount | LEU mg | PRO gm | Energy kcal |
6 AM | Formula | 8 oz | 86 | 4.8 | 180 |
9 AM | Baby food, rice cereal, dry (mixed with water or formula from daily allotment) | 1.5 TBS | 21 | 0.3 | 15 |
Applesauce | 1 TBS | 2 | 0 | 9 | |
11 AM | Formula | 8 oz | 86 | 4.8 | 180 |
3 PM | Formula | 8 oz | 86 | 4.8 | 180 |
6 PM | Pureed sweet potatoes Applesauce | 1 TBS 1 TBS | 8 2 | 0.2 0 | 10 9 |
8 PM | Formula | 8 oz | 86 | 4.8 | 180 |
TOTAL INTAKE | 377 mg | 19.7 g | 763 kcal | ||
Per kg BW | 47 mg | 2.5 g | 95 kcal |
AGE | Individual >4 years of age (classical to mild MSUD) | |||||
NUTRIENT | ||||||
LEU mg/d | Approx Intact PRO g/kg | ILE mg/d | VAL mg/d | Total PRO g/kg | ENERGY kcal/kg | |
>4 yr | 275-500 | 5.0 - 8.0 | 250-450 | 325-500 | 120% DRI | DRI |
As there is a range in the recommendations for the BCAA, energy and PRO, monitoring growth, clinical status and biochemical markers is essential when prescribing the nutrient intake for any individual with MSUD. There may be some individuals who will need intakes outside the recommended ranges for optimal outcome. If monitoring results are consistent with good control, dietary modifications such as introduction of solid foods or change in formula mixture should be based on current intake.
This table is an excerpt of TABLE #4, Recommended Dietary PRO, BCAA and Energy Intake from the Nutrition Management Guideline for MSUD where more details are provided.
Meal | Food/beverage items | Amount | LEU mg | PRO g | Energy kcal |
Breakfast | Cereal, puffed rice | 1 cup (14 g) | 74 | 0.9 | 56 |
Banana | 1 medium | 80 | 1.3 | 105 | |
Rice milk, unsweetened | 4 oz | 9 | 0.2 | 24 | |
BCAD-2 | 30 g (plus water to make 8 oz total) | 0 | 7.2 | 123 | |
Lunch | Half sandwich: low-protein bread apple butter | 1 slice 2 TBS | 7 7 | 0.1 0.1 | 130 59 |
Carrot sticks | 36 g | 37 | 0.3 | 15 | |
Wise onion rings | 1 pkg (14 g) | 7 | 0.3 | 70 | |
Lemon pudding cup | 1 snack cup | 9 | 0.1 | 124 | |
MSUD cooler 15 | 1 pouch (130 mL) | 0 | 15 | 92 | |
Snack | Popcorn, microwave, butter-flavored | 1 cup | 84 | 0.7 | 43 |
Apple juice | 4 oz | 4 | 0.1 | 58 | |
Dinner | Pasta, low-protein, cooked | 1/3 cup, dry | 16 | 0.3 | 203 |
Marinara sauce | ½ cup | 66 | 2.1 | 74 | |
Broccoli, cooked | ½ cup | 115 | 1.9 | 27 | |
Low-protein bread, toasted Garlic butter | 1 slice 1 tsp | 7 4 | 0.1 0 | 130 34 | |
Watermelon, diced | 1 cup | 27 | 0.9 | 46 | |
BCAD-2 | 30 g (plus water to make 8 oz total) | 0 | 7.2 | 123 | |
TOTALS | 551mg | 38.7g | 1532 kcal | ||
Per kg actual weight (20 kg) | 28 mg | 1.9 g | 77 kcal |
Component | Goal | Source(s) |
Energy | 150% of recommended 1,2 | Enteral: BCAA-free medical food and, as needed, other BCAA/PRO free energy sources - e.g., Solcarb (Solace Nutrition), S.O.S. (Vitaflo USA),Pro-Phree (Abbott Nutrition), Duocal (Nutricia); PFD (Mead Johnson) |
Parenteral2: 10% glucose/dextrose3, 20% Intralipids @ 2 gm/kg/day. | ||
BCAA-free AA | 120-150% of recommended | Enteral: BCAA-free medical food4 |
Parenteral: BCAA-free specialty TPN6 | ||
Fluids and electrolytes | Individualized3,5 | Enteral: additional protein-free oral fluids,e.g., juices, sport drinks |
Parenteral5: Glucose/dextrose solutions and TPN | ||
BCAA (ILE and VAL) | 20-120 mg/kg/day6 for each | Enteral: may be added to the medical food, as weighed powder, or in appropriate volume of 1% solutions |
Parenteral: from specialty pharmacies. Or, if no parenteral form is available, use small volumes given orally, or slow drip by NG or g-tube. | ||
Insulin7 | to prevent or reverse hyperglycemia |
1. To promote anabolism, an increase in the recommended intake TABLE #4, Recommended Dietary PRO, BCAA and Energy Intake based on age and ideal weight for healthy individuals with MSUD).
2. More concentrated solutions are possible if access is through a PICC/central line
3. Glucose solution given at a rate of 1.5-2 X maintenance is possible but never use maximum rate unless constant monitoring confirms there is no brain edema or electrolyte imbalance
4. Provide not only the recommended PRO for age and size, but also replace the sources of intact PRO removed to restrict BCAA and add additional energy
5. Although dehydration and acid-base imbalance are often seen during illness, very careful monitoring is needed to prevent cerebral edema from fluid overload and electrolyte imbalance
6. To reach and maintain blood VAL and ILE goals of ~ 400 µM, added VAL and LEU are needed during the acute phase of illness to help decrease LEU levels by providing substrate for PRO synthesis and prevent ILE and VAL deficiencies.
7. Insulin may be necessary to maximize glucose utilization and prevent hyperglycemia
Assessment | Intervals1 |
BCAA by plasma amino acids | 12 hr or as indicated |
Sodium, potassium, water balance | 12 hr or as indicated |
Glucose | 12 hr or as indicated |
Clinical signs of intracranial pressure | continuously |
Weight and urine output | Daily, or as indicated |
Urine osmolarity | Daily, or as indicated |
1. Intervals dependent on clinical judgement of intensive care and metabolic physicians as well as facility resources. For further discussion and details of acute illness care see: R.3 and R.25
Age/Stage | PREGNANCY and POSTPARTUM (classical MSUD) | |||||
NUTRIENT | ||||||
LEU mg/kg | Approx Intact PRO g/day | ILE mg/day | VAL mg/day | Total PRO g/day | ENERGY kcal/day | |
1st trimester | 300 - 500 | 5.0 - 8.0 | 250-450 | 325-500 | 120% DRI plus 0.5g/d | DRI plus 85 kcal/d |
2nd trimester | 600 -1000 | 10 - 16 | 400-800 | 600-1000 | 120% DRI plus 7.7g/d | DRI plus |
3rd trimester | 800 - 2000 | 13 - 33 | 650-1200 | 800-1800 | 120% DRI plus 25g/d | DRI plus |
Postpartum | If not breast feeding, return to pre-pregnancy intake | |||||
Lactation | Intake while breastfeeding should be approximately the same as in the 3rd trimester |
As there is a range in the recommendations for the BCAA, energy and PRO, monitoring growth, clinical status and biochemical markers is essential when prescribing the nutrient intake for any individual with MSUD. There may be some individuals who will need intakes outside the recommended ranges for optimal outcome. If monitoring results are consistent with good control, dietary modifications such as introduction of solid foods or change in formula mixture should be based on current intake.
This table is an excerpt of TABLE #4, Recommended Dietary PRO, BCAA and Energy Intake from the Nutrition Management Guideline for MSUD where more details are provided.
AGE | LEU mg/day | Intact PRO g/day | ILE mg/day | VAL mg/day | Total PRO g/day | Energy Kcal/day |
19+ years | 275-500 | 5.0-8.0 | 250-450 | 325-500 | 120% DRI1 | DRI |
1 DRI for PRO for adult (non-pregnant) women is 46 g/day; for women with MSUD recommended intake is 55 g (120% of DRI).
As there is a range in the recommendations for the BCAA, energy and PRO, monitoring growth, clinical status and biochemical markers is essential when prescribing the nutrient intake for any individual with MSUD. Some individuals may need intakes outside the recommended ranges for optimal outcome. If monitoring results are consistent with good control, dietary modifications such as change in medical food mixture should be based on current intake.
Meal | Food/beverage items | Amt | LEU mg | PRO g | Energy Kcal |
Breakfast | Hash brown patty (frozen) | 1 (29 g) | 57 | 0.77 | 63 |
Catsup | ½ TBS | 2 | 0.09 | 9 | |
Frosted rice flakes | ½ cup (16 g) | 114 | 1.36 | 109 | |
Unsweetened rice milk beverage | ½ cup (4 oz) | 9 | 0.15 | 24 | |
Medical Food | 1 cup (8 oz) | - | 20 | 230 | |
Lunch | Low protein pasta salad 1 | 1 cup | 32 | 0.55 | 378 |
Baby carrots | 8 | 28 | 0.50 | 28 | |
Fresh pear | 1 (medium) | 34 | 0.64 | 101 | |
Medical Food | 1 cup (8 oz) | - | 20 | 230 | |
Snack | Apple chips | 12 (28 g) | 12 | 0.20 | 140 |
Dinner | Vegetarian chili 1 | 1.5 cups (12 oz) | 157 | 3.0 | 140 |
Low protein tortillas 1 | 2 (8 inch) | 6 | 0.16 | 208 | |
Margarine | 2 tsp | 8 | 0.09 | 69 | |
Medical Food | 1 cup (8 oz) | - | 20 | 230 | |
Snack | Hunts lemon pudding | One snack pack (90 g) | - | - | 124 |
Sugar wafers | 4 (14 g) | 36 | 0.54 | 70 | |
Totals Amt /kg BW | 495mg 8.4 mg/kg BW | 68g 1.15g/kg BW | 2153Kcal 36/kg BW |
1 Recipes found in R.109
Components | Amt | LEU mg | Approx Intact PRO g | ILE mg | VAL mg | Total PRO g | Energy Kcal |
Complex Essential MSD Drink Mix | 160 g (4 scoops) | 0 | 0 | 0 | 0 | 40 | 608 |
Complex MSD AA blend | 25 g (2 scoops) | 0 | 0 | 0 | 0 | 20 | 81 |
L-isoleucine, 20 mg/mL solution | 10 mL | 0 | 0 | 200 | 0 | 0.2 | 1.32 |
L-valine, 20 mg/mL solution | 15 mL | 0 | 0 | 0 | 300 | 0.3 | 1.82 |
Water to make 23 oz | |||||||
Food | varies | ~5001 | 8.3 | ~2801 | ~2251 | ~8.3g | ~1463 |
Totals Amt /kg BW | ~500mg 8.5mg/kg BW | 8.3g 0.14g/kg BW | ~480mg 8.1mg/kg BW | ~525mg 8.9mg/kg BW | ~68g3 1.2g/kg BW | ~2153Kcal 36Kcal/kg BW |
1Approximate BCAA content of protein in a mixed diet is:
LEU: 60 mg/g PRO
ILE: 27 mg/g PRO
VAL: 34 mg/g PRO
2negligible contribution to energy, may count as zero
3 DRI for PRO for adult (non-pregnant) women is 46 g/day; for women with MSUD, the recommended intake is 55 g (120% of DRI).
Meal | Food/beverage items | Amount | LEU mg | PRO g | Energy Kcal |
Breakfast | Hash brown patty (frozen) | 1 (29 g) | 57 | 0.77 | 63 |
Catsup | 1 TBS | 4 | 0.18 | 18 | |
Honey Nut Cheerios | 1 cup (28 g) | 366 | 2.63 | 109 | |
Unsweetened rice milk beverage | ½ cup (4 oz) | 9 | 0.15 | 24 | |
Non-dairy liquid creamer | ¼ cup (2 oz) | 51 | 0.60 | 81 | |
Medical food | 1 cup (8 oz) | - | 20 | 230 | |
Snack | Granola bar | 1 (23 g) | 116 | 1.6 | 93 |
Lunch | Pasta salad with regular pasta 1 | 1 cup | 682 | 10.0 | 390 |
Baby carrots | 8 | 28 | 0.50 | 28 | |
Fresh pear | 1 (large) | 44 | 0.83 | 131 | |
Medical food | 1 cup (8 oz) | - | 20 | 230 | |
Snack | Apple chips | 12 (28 g) | 12 | 0.20 | 140 |
Fruit Punch | 1 cup (8 oz) | - | 0.25 | 115 | |
Dinner | Vegetarian chili with 2 TBS kidney beans 1 | 1.5 cups (12 oz) | 353 | 5.66 | 186 |
Flour tortillas | 2 (6 inch) | 219 | 4.92 | 200 | |
Margarine | 1 TBS | 11 | 0.09 | 101 | |
Medical food | 1 cup (8 oz) | - | 20 | 230 | |
Snack | Hunts lemon pudding | 1 snack pack (90 g) | - | - | 124 |
Chocolate chip cookies | 4 (medium 2 ¼") | 160 | 2.16 | 192 | |
Totals Amt/kg BW | 2112mg 31mg/kg BW | 90.54g 1.33 g/kg BW | 2685Kcal 39 Kcal/kg BW |
1 Recipes in R.109 and modified in the above menu
Components | Amt | LEU mg | Approx Intact PRO g | ILE mg | VAL mg | Total PRO g | ENERGY Kcal |
Complex Essential MSD Drink Mix | 160 g (4 scoops) | 0 | 0 | 0 | 0 | 40 | 609 |
Complex MSD AA blend | 25 g (2 scoops) | 0 | 0 | 0 | 0 | 20 | 81 |
L-isoleucine 20mg/mL | 4mL | 0 | 0 | 80 | 0 | 0.08 | 0.252 |
L-valine 20mg/mL | 25mL | 0 | 0 | 0 | 500 | 0.5 | 32 |
Water to make 23 oz | |||||||
Food | varies | 2,1121 | 30 | 1,2221 | 1,3331 | 30 | 1995 |
Totals Amt /kg BW | 2,112mg 31mg/kg BW | 30g3 0.44g/g BW | 1302mg 19mg/kg BW | 1833mg 27mg/kg BW | 90.6g 1.33g/kg BW | 2685Kcal 39Kcal/kg BW |
1 Calculated from MetabolicPro for the menu modified to increase protein
2negligible contribution to energy, may count as zero
3 Intact PRO intake increased 3.6-fold